ACC 2018ConferencesPodcasts CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients Sadaf Sharfaei, M.D. Share 0 Min Read Dr. Ridker and Dr. C. Michael Gibson Subscribe on iTunes or Google Play. TAGGED:ACC 2018ConferenceFeatured Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
